BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10088933)

  • 21. Long term tidal breathing measurements in newborns: influence of a bias flow on ventilatory parameters.
    Windstetter D; Foitzik B; Schmalisch G; Wauer R
    Eur J Med Res; 1999 Jan; 4(1):15-22. PubMed ID: 9892570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An alternative to steroids for prevention of respiratory distress syndrome (RDS): multicenter controlled study to compare ambroxol and betamethasone.
    Luerti M; Lazzarin A; Corbella E; Zavattini G
    J Perinat Med; 1987; 15(3):227-38. PubMed ID: 3323457
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evolution of respiratory mechanics in preterm babies after surfactant administration in the neonatal period.
    Parmigiani S; Panza C; Bevilacqua G
    Acta Biomed Ateneo Parmense; 1997; 68 Suppl 1():65-73. PubMed ID: 10021719
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Ambroxol for the prevention of respiratory distress syndrome in preterm infants: a meta analysis].
    Zhang ZQ; Huang XM; Lu H
    Zhongguo Dang Dai Er Ke Za Zhi; 2010 Nov; 12(11):858-63. PubMed ID: 21083978
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Postnatal changes in pulmonary mechanics and energetics of infants with respiratory distress syndrome following surfactant treatment.
    Bhutani VK; Bowen FW; Sivieri EM
    Biol Neonate; 2005; 87(4):323-31. PubMed ID: 15985755
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in dead space/tidal volume ratio and pulmonary mechanics after surfactant replacement therapy in respiratory distress syndrome of the newborn infants.
    Chung EH; Ko SY; Kim IY; Chang YS; Park WS
    J Korean Med Sci; 2001 Feb; 16(1):51-6. PubMed ID: 11289401
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pulmonary mechanics and energetics in preterm infants who had respiratory distress syndrome treated with synthetic surfactant.
    Bhutani VK; Abbasi S; Long WA; Gerdes JS
    J Pediatr; 1992 Feb; 120(2 Pt 2):S18-24. PubMed ID: 1735846
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Compliance of the respiratory system as a predictor for successful extubation in very-low-birth-weight infants recovering from respiratory distress syndrome.
    Smith J; Pieper CH; Maree D; Gie RP
    S Afr Med J; 1999 Oct; 89(10):1097-102. PubMed ID: 10582068
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of early dexamethasone therapy on pulmonary mechanics and chronic lung disease in very low birth weight infants: a randomized, controlled trial.
    Durand M; Sardesai S; McEvoy C
    Pediatrics; 1995 Apr; 95(4):584-90. PubMed ID: 7700763
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Ambroxol].
    Akkoca Yildiz O
    Tuberk Toraks; 2006; 54 Suppl 1():3-14. PubMed ID: 17089236
    [No Abstract]   [Full Text] [Related]  

  • 31. [Ambroxol in the treatment of idiopathic respiratory distress syndrome].
    Durisová A
    Cesk Pediatr; 1992 Jul; 47(7):421-3. PubMed ID: 1394543
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pulmonary function testing prior to extubation in infants with respiratory distress syndrome.
    Veness-Meehan KA; Richter S; Davis JM
    Pediatr Pulmonol; 1990; 9(1):2-6. PubMed ID: 2388775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Ambroxol versus betamethasone for stimulating antepartal lung maturity--a multicenter study].
    Salzer H; Weidinger H; Simbruner G; Vytiska-Binstorfer E
    Z Geburtshilfe Perinatol; 1986; 190(1):49-59. PubMed ID: 3515786
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Response to added dead space in ventilated preterm neonates and outcome of trial of extubation.
    Fox GF; Alexander J; Marsh MJ; Milner AD
    Pediatr Pulmonol; 1993 May; 15(5):298-303. PubMed ID: 8327289
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of Two Different Exogenous Surfactant Preparations on Serial Peripheral Perfusion Index and Tissue Carbon Monoxide Measurements in Preterm Infants with Severe Respiratory Distress Syndrome.
    Terek D; Gonulal D; Koroglu OA; Yalaz M; Akisu M; Kultursay N
    Pediatr Neonatol; 2015 Aug; 56(4):248-55. PubMed ID: 25603725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in pulmonary mechanics after the administration of surfactant to infants with respiratory distress syndrome.
    Davis JM; Veness-Meehan K; Notter RH; Bhutani VK; Kendig JW; Shapiro DL
    N Engl J Med; 1988 Aug; 319(8):476-9. PubMed ID: 3405254
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-dose Oral Ambroxol for Early Treatment of Pulmonary Acute Respiratory Distress Syndrome: an Exploratory, Randomized, Controlled Pilot Trial.
    Baranwal AK; Murthy AS; Singhi SC
    J Trop Pediatr; 2015 Oct; 61(5):339-50. PubMed ID: 26130623
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Ambroxol in comparison with betamethasone for the stimulation of antepartal lung maturity. A clinical double-blind study].
    Vytiska-Binstorfer E; Salzer H; Simbruner G
    Zentralbl Gynakol; 1986; 108(4):220-9. PubMed ID: 3518290
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cord blood prolactin and thyroid hormone levels after antenatal administration of betamethasone or ambroxol for prevention of respiratory distress syndrome (RDS).
    Luerti M; Spagnolo D; Zavattini G; Bianchi C; Barbera AG; Corbella E
    Biol Res Pregnancy Perinatol; 1984; 5(3):124-9. PubMed ID: 6548163
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic effect of micropump intravenous infusion of ambroxol hydrochloride on respiratory distress syndrome in premature infants.
    Xu JS; Li BH; Xu YQ; Li J; Lin Y
    Eur Rev Med Pharmacol Sci; 2023 Jun; 27(11):5105-5118. PubMed ID: 37318484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.